Novaliq
PrivateLast Round
VC Round
Oct 11, 2018
Total Funding Raised
$17.8M
Company Overview
Novaliq is a biopharmaceutical company that develops and commercializes ocular therapeutics based on its proprietary EyeSol® water-free technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novaliq Comparables
Compare Novaliq with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bausch + Lomb Corporation | 84% | |
| Harrow, Inc. | 79% | |
| Aldeyra Therapeutics | 76% | |
Novaliq Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 11, 2018 | ||||
| VC Round | Apr 11, 2013 | ||||
| VC Round | May 4, 2012 | ||||
| VC Round | Jul 27, 2011 |
Key People
Founding team and executive leadership
Novaliq Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| dievini Hopp BioTech holding | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
EyeSol technology drug approved in China in 2025.
- Jan 1, 2024
EyeSol technology drug received regulatory approval in Europe in 2024.
Novaliq Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Novaliq's valuation, stock price, and market status.